Meeting Banner
Abstract #1347

Image-Based Measurement of T2* for Dissolved-Phase Xe129 in the Human Lung

John P. Mugler, III1, Talissa A. Altes1, Iulian C. Ruset2, 3, G. Wilson Miller1, Jaime F. Mata1, Kun Qing4, Igor Tsentalovich2, F. William Hersman2, 3, Kai Ruppert1

1Radiology & Medical Imaging, University of Virginia, Charlottesville, VA, United States; 2Physics, University of New Hampshire, Durham, NH, United States; 3Xemed, LLC, Durham, NH, United States; 4Biomedical Engineering, University of Virginia, Charlottesville, VA, United States

The T2* of dissolved-phase Xe129 in the lung was measured in three healthy subjects. Median T2* values ranged between 2.0 and 2.3 ms.

Keywords

achieve acquisition additional although approved approximately assess assuming assumption basis biological biomedical blood board breath built cell characteristics chemical chest coil collisional combined compartments component components composite confirm consent containing contains contributions coronal correspond custom decay demonstrating depiction described despite determine direct directly disease dissolved dissolves efficiently engineering enormous enriched environment exchange expected exploring exponential exquisite fashion feasibility female fraction frequency function gradient grants healthy histogram hold human informed inhalation inhaled insights institutional insufficient intensity interleaved john lung magnitude make male maps maximizing median medical miller mixture modulation mono necessary need needed noise nonetheless optimization oxygen particularly physician physics pixel plasma polarized potential projection proportion protocol proton providing radiology recent relatively resolution review rigid room rubidium sensitivity separated sequential short simultaneous since solubility solution solutions spatial spectra spectral spin step studies subject subjects substantial substantially supported suppressed system tissue tissues toward twice uniform upon uptake useful validity vapor whole xenon yield